105 related articles for article (PubMed ID: 17971413)
21. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
22. Analysis of growth factor "relaxation" in Chinese hamster lung fibroblasts required for tumoral expression.
Van Obberghen-Schilling E; Pérez-Rodríguez R; Franchi A; Chambard JC; Pouysségur J
J Cell Physiol; 1983 May; 115(2):123-30. PubMed ID: 6188755
[TBL] [Abstract][Full Text] [Related]
23. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
25. LRP1 modulates APP trafficking along early compartments of the secretory pathway.
Waldron E; Heilig C; Schweitzer A; Nadella N; Jaeger S; Martin AM; Weggen S; Brix K; Pietrzik CU
Neurobiol Dis; 2008 Aug; 31(2):188-97. PubMed ID: 18559293
[TBL] [Abstract][Full Text] [Related]
26. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution.
Muramatsu H; Shirahama H; Yonezawa S; Maruta H; Muramatsu T
Dev Biol; 1993 Oct; 159(2):392-402. PubMed ID: 8405666
[TBL] [Abstract][Full Text] [Related]
27. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
29. Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation.
Tucker LA; Zhang Q; Sheppard GS; Lou P; Jiang F; McKeegan E; Lesniewski R; Davidsen SK; Bell RL; Wang J
Oncogene; 2008 Jun; 27(28):3967-76. PubMed ID: 18264137
[TBL] [Abstract][Full Text] [Related]
30. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
31. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA.
Lintzel J; Franke I; Riedel IB; Schaller HC; Hampe W
Biol Chem; 2002 Nov; 383(11):1727-33. PubMed ID: 12530537
[TBL] [Abstract][Full Text] [Related]
33. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
[TBL] [Abstract][Full Text] [Related]
36. SorCS3 does not require propeptide cleavage to bind nerve growth factor.
Westergaard UB; Kirkegaard K; Sørensen ES; Jacobsen C; Nielsen MS; Petersen CM; Madsen P
FEBS Lett; 2005 Feb; 579(5):1172-6. PubMed ID: 15710408
[TBL] [Abstract][Full Text] [Related]
37. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.
Cattaruzza S; Schiappacassi M; Kimata K; Colombatti A; Perris R
FASEB J; 2004 Apr; 18(6):779-81. PubMed ID: 14977887
[TBL] [Abstract][Full Text] [Related]
38. Midkine and pleiotrophin in neural development and cancer.
Kadomatsu K; Muramatsu T
Cancer Lett; 2004 Feb; 204(2):127-43. PubMed ID: 15013213
[TBL] [Abstract][Full Text] [Related]
39. Minimization of the third domain of the LDL receptor-associated protein (RAP).
Isbell SL; Haslam SB; Zankel TC
Biochem Biophys Res Commun; 2007 Sep; 361(3):758-62. PubMed ID: 17678622
[TBL] [Abstract][Full Text] [Related]
40. LDL receptor-related protein and the vascular wall: implications for atherothrombosis.
Llorente-Cortés V; Badimon L
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):497-504. PubMed ID: 15705932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
